日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Country working on vaccines for novel coronavirus variants

By ZOU SHUO and ZHANG YANGFEI | CHINA DAILY | Updated: 2021-03-29 07:18
Share
Share - WeChat
Teachers and students are vaccinated at East China Normal University's Minhang campus stadium in Shanghai on Sunday. [Photo/XINHUA]

Inoculations in use found to have a good neutralizing effect on strains

China is advancing the development of COVID-19 vaccines against variants of the novel coronavirus, and experiments have shown the inactivated vaccines currently used in the country are effective against them.

Zhang Yuntao, vice-president of China National Biotech Group, a subsidiary of State-owned pharmaceutical giant Sinopharm, told a news conference on Sunday that researchers have been testing the antiviral-mutation ability of the inactivated vaccines.

By using data from mid-and late-stage clinical trials in China and overseas, researchers have conducted experiments on a dozen variants, including those found in South Africa and the United Kingdom, Zhang said.

The experiments have found that the antibodies produced by the two inactivated vaccines have a good neutralizing effect on all the tested strains, he said, adding that such experiments are continuing on strains found in Brazil and Zimbabwe.

Three inactivated vaccines have won conditional approval for market use in China. Two were developed and manufactured by Sinopharm and the other by Sinovac Biotech.

Zhang said virus mutations will always occur and cannot be prevented, but small mutations will not alter the effectiveness of vaccines.

Various COVID-19 variants have been identified since late last year. While no evidence has emerged that they cause more severe illness in the majority of infected people, they were found to be more contagious.

Gao Qiang, general manager of Sinovac Biotech, told the news conference that the company has started research and development of vaccines against the variants discovered in South Africa and Brazil.

Based on earlier cross-neutralization research on mutated strains found in 10 countries, its vaccine has proved to be effective, he said.

The two executives said they have gained rich experience in vaccine research and development and will be able to respond quickly and effectively to mutant strains.

Separately, China had administered more than 100 million doses of COVID-19 vaccines by Saturday, the National Health Commission said.

The country will actively and prudently advance the COVID-19 vaccination of people over 60 and those who have chronic disease, based on the effectiveness of its mass vaccination campaign, commission official Wu Liangyou said.

Beijing and Shanghai have started vaccinating people over 60 who are in good health and those who have chronic disease, Wu said.

Zhang said China National Biotech Group will start consultations with the National Medical Products Administration on the vaccination of those aged between 3 and 17, and it is expected to start soon.

The company started early and mid-stage clinical trials of vaccinations for people in that age group in Henan province last year, Zhang said.

The trials have shown that the vaccine's safety met expectations, and data on its effectiveness has also been obtained, he said.

Wang Huaqing, chief vaccination planning expert at the Chinese Center for Disease Control and Prevention, said although there is no comprehensive late-stage clinical trial data on vaccination of people under 18, it will be obtained as clinical trials progress.

China has given consideration to vaccinating people under 18, including newborns, and it will continue to improve its vaccination plan based on the epidemic situation and clinical trial data, he said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 欧美一级毛片在线看视频 | 天堂在线资源av | 亚洲不卡视频 | 国产一区二区久久精品 | 国产在线小视频 | 日韩第3页 | 国产成人羞羞视频在线 | jdav视频在线观看免费 | 国产免费av在线 | 91好色视频 | 美国黄色毛片女人性生活片 | 精品久久久久久久 | 欧美伊人久久综合网 | 久草福利在线视频 | 国产亚洲精品久久久久久无码网站 | 成人欧美一区二区三区 | 性做久久久久免费看 | 香蕉视频观看 | 天堂一区 | 精品国产一区二区国模嫣然 | 免费看一级毛片 | 天天操夜夜嗨 | 国产精品久久久久久久久久iiiii | 精品人人视屏 | 亚洲精品视 | 国产一区二区三区高清 | 亚洲欧美日本人成在线观看 | 欧美视频在线观看 | 久久久日韩精品一区二区 | 久草视频网站 | 闲人综合网 | 国产精品成人av | 中文字幕精品一区二区三区精品 | 欧美一级色片 | 成人性爱视频在线观看 | 一区二区三区四区免费看 | 日韩黄色在线视频 | 狠狠色狠狠色综合久久第一次 | 欧美另类videosbestsex久久 | 性夜影院爽黄e爽在线观看 苏晓晖个人简介军衔 | 久久成人在线视频 |